Clinical Trials Logo

Clinical Trial Summary

Evaluation of "UroShield" device impact upon side effects and complications of urinary catheter usage.

The use of urinary catheters is a common medical practice in the perioperative setting.

As such, it exposes the patient to certain comorbidities, including urinary tract infections.

The infectious process is known to begin with a development of a biofilm on the catheter's surface. This fact makes it an attractive target for UTI prevention technology.

Ultrasound waves were shown to reduce biofilm buildup in-vitro. We plan to determine the efficacy of this method in vivo.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02412891
Study type Interventional
Source HaEmek Medical Center, Israel
Contact
Status Withdrawn
Phase N/A
Start date August 2015
Completion date August 2017

See also
  Status Clinical Trial Phase
Completed NCT00772447 - China Registration Study in Patients With Skin Infections Phase 3
Completed NCT00381303 - GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. Phase 3
Completed NCT01520597 - National Study on Listeriosis and Listeria
Completed NCT01326013 - A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel Phase 2
Not yet recruiting NCT04490772 - Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
Completed NCT06006078 - Aersosolization During Upper Endoscopy N/A